Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 191-200 of 3561 for cancer

Edit search filters
  1. A Study to Test Combination Treatments in Patients With Advanced Gastric Cancer

    Jacksonville, FL, Rochester, MN, Scottsdale/Phoenix, AZ

  2. A Safety and Efficacy Study of Intravenous (IV) Elezanumab Assessing Change in Neurologic Function in Adult Participants With Acute Ischemic Stroke (EAISE)

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  3. Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant

    Jacksonville, FL, Rochester, MN

  4. A Study of BBI503 in Asymptomatic Recurrent Ovarian Cancer Patients With CA-125 Elevation

    Rochester, MN

  5. A Study Of Single Patient Investigational Drug CPI-613 For Use In Treatment-Refractory, Metastatic Prostate Cancer

    Rochester, MN

  6. Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)

    Jacksonville, FL, Rochester, MN

  7. Advancing Survivorship Support through Virtual Health Equity Resources for Breast Cancer Responsive Education

    Jacksonville, FL

  8. Auranofin and Sirolimus in Treating Participants With Ovarian Cancer

    Rochester, MN

  9. A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer

    Scottsdale/Phoenix, AZ

  10. DAREON™-9: A Study To Test How Well Different Doses Of BI 764532 Are Tolerated By People With Small Cell Lung Cancer When Taken Together With A Single Agent Chemotherapy

    Jacksonville, FL

.

Mayo Clinic Footer